11:08 EDT Pelthos Therapeutics (PTHS) Inc trading halted, volatility trading pause
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTHS:
- Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer
- Pelthos Highlights 2025 Results and Portfolio Expansion Progress
- Pelthos Therapeutics reports Q4 EPS ($6.87) vs. ($3.19) last year
- PTHS Earnings this Week: How Will it Perform?
- Pelthos Therapeutics initiated with an Overweight at Piper Sandler